PharmaCyte Biotech Stock (NASDAQ: PMCB) stock price, news, charts, stock research, profile.
You can purchase shares of PharmaCyte Biotech (NASDAQ:PMCB) through any online brokerage.
Other companies in PharmaCyte Biotech’s space includes: NKGen Biotech (NASDAQ:NKGN), Immuron (NASDAQ:IMRN), Imunon (NASDAQ:IMNN), Can Fite Biofarma (AMEX:CANF) and Nanoviricides (AMEX:NNVC).
There is no analysis for PharmaCyte Biotech to provide a consensus price target.
The stock price for PharmaCyte Biotech (NASDAQ: PMCB) is $1.89 last updated November 19, 2024 at 5:16 PM EST.
There are no upcoming dividends for PharmaCyte Biotech.
PharmaCyte Biotech’s Q2 earnings are confirmed for Friday, December 13, 2024.
There is no upcoming split for PharmaCyte Biotech.
PharmaCyte Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.